Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis-Reference-Cited by-同舟云学术

Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis

Published:2021-03 Issue:3 Volume:19 Page:511-518.e6
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Battat Robert^ORCID,Hemperly Amy,Truong Stephanie,Whitmire Natalie,Boland Brigid S.,Dulai Parambir S.,Holmer Ariela K.,Nguyen Nghia H.^ORCID,Singh Siddharth,Vande Casteele Niels^ORCID,Sandborn William J.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. The pattern and outcome of acute severe colitis;Dinesen;J Crohns Colitis,2010

2. Review article: dose optimisation of infliximab for acute severe ulcerative colitis;Hindryckx;Aliment Pharmacol Ther,2017

3. Review article: the practical management of acute severe ulcerative colitis;Seah;Aliment Pharmacol Ther,2016

4. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

5. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab;Sandborn;Gastroenterology,2009

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022;Frontiers in Pharmacology;2024-07-08

2. Colombian experience with the use of tofacitinib in severe acute ulcerative colitis: A case series study;Gastroenterología y Hepatología (English Edition);2024-06

3. What to do when traditional rescue therapies fail in acute severe ulcerative colitis;Intestinal Research;2024-05-16

4. Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling study;Intestinal Research;2024-05-07

5. Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU);Gastroenterología y Hepatología;2024-05